Prevention of endothelial dysfunction in streptozotocin-induced diabetic rats by gliclazide treatment
- 1 July 2000
- journal article
- research article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 14 (4) , 224-233
- https://doi.org/10.1016/s1056-8727(00)00079-9
Abstract
No abstract availableKeywords
Funding Information
- Comisión Interministerial de Ciencia y Tecnología (08.4/0027/1998, 98-0010, SAF 96-0142)
- European Regional Development Fund (2FD97-0445-CO2)
- Servier
- Comunidad de Madrid
This publication has 33 references indexed in Scilit:
- Impairment of nitric oxide-mediated relaxations in anaesthetized autoperfused streptozotocin-induced diabetic ratsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1998
- Microvascular permeability with sulfonylureas in normal and diabetic hamstersMetabolism, 1997
- Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDLMetabolism, 1997
- Impairment of Endothelium-Dependent Relaxation by Increasing Percentages of Glycosylated Human HemoglobinHypertension, 1996
- Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stressDiabetologia, 1993
- Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes.Journal of Clinical Investigation, 1992
- Metabolic Control May Influence the Increased Superoxide Generation in Diabetic SerumDiabetic Medicine, 1991
- Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.Journal of Clinical Investigation, 1991
- The mode of action and clinical pharmacology of gliclazide: a reviewDiabetes Research and Clinical Practice, 1991
- Impairment of endothelium‐dependent relaxation in aortae from spontaneously diabetic ratsBritish Journal of Pharmacology, 1988